ABSI (STOCKS)
Absci Corporation Common Stock
$7.270200
+0.470200 (+6.91%)
Prev close: $6.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sean McClain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,134.21M
- Employees
- 157
- P/E (TTM)
- -8.20
- P/B (TTM)
- 6.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.19 | $-0.21 | +0.0242 | +11.30% |
|
Dec 2025 (Q4)
|
$-0.20 | $-0.20 | -0.0018 | -0.91% |
|
Sep 2025 (Q3)
|
$-0.20 | $-0.22 | +0.0159 | +7.36% |
|
Jun 2025 (Q2)
|
$-0.24 | $-0.22 | -0.0238 | -11.01% |
Financial Statements
| Revenues | $1.84M |
| Benefits Costs and Expenses | $120.18M |
| Costs And Expenses | $120.18M |
| Nonoperating Income/Loss | $5.09M |
| Operating Expenses | $125.27M |
| Selling, General, and Administrative Expenses | $34.64M |
| Research and Development | $84.33M |
| Other Operating Expenses | $6.30M |
| Operating Income/Loss | -$123.43M |
| Income/Loss From Continuing Operations After Tax | -$118.44M |
| Income/Loss From Continuing Operations Before Tax | -$118.35M |
| Income Tax Expense/Benefit | $91.00K |
| Net Income/Loss | -$118.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$118.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$118.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.82 |
| Diluted Earnings Per Share | -$0.82 |
| Basic Average Shares | 428,986,429 |
| Diluted Average Shares | 428,986,429 |
| Assets | $195.59M |
| Current Assets | $131.97M |
| Noncurrent Assets | $63.62M |
| Intangible Assets | $40.77M |
| Other Non-current Assets | $22.85M |
| Liabilities | $23.62M |
| Current Liabilities | $20.03M |
| Accounts Payable | $8.83M |
| Wages | $2.22M |
| Other Current Liabilities | $8.99M |
| Noncurrent Liabilities | $3.59M |
| Equity | $171.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $171.97M |
| Liabilities And Equity | $195.59M |
| Net Cash Flow From Operating Activities | -$97.39M |
| Net Cash Flow From Operating Activities, Continuing | -$97.39M |
| Net Cash Flow From Investing Activities | -$27.75M |
| Net Cash Flow From Investing Activities, Continuing | -$27.75M |
| Net Cash Flow From Financing Activities | $70.71M |
| Net Cash Flow From Financing Activities, Continuing | $70.71M |
| Net Cash Flow | -$54.44M |
| Net Cash Flow, Continuing | -$54.44M |
| Comprehensive Income/Loss | -$118.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$118.15M |
| Other Comprehensive Income/Loss | -$87.87M |